Whitcroft K L, Ezzat M, Cuevas M, Andrews P, Hummel T
Department of Otorhinolaryngology, Interdisciplinary Center for Smell and Taste, TU Dresden, Dresden, Germany.
Department of Rhinology and Facial Plastic Surgery, Royal National Throat Nose and Ear Hospital, London, UK.
Clin Otolaryngol. 2017 Jun;42(3):557-563. doi: 10.1111/coa.12789. Epub 2016 Dec 7.
Free calcium plays an integral role in peripheral olfactory processing, including feedback inhibition. It has therefore been suggested that reduction of intranasal free calcium with buffer solutions such as sodium citrate may improve olfactory function in patients with smell impairment. Several previous studies have supported this hypothesis, particularly in post-infectious olfactory loss. We therefore aimed to determine whether treatment with intranasal sodium citrate improves olfactory function in patients with post-infectious impairment.
Prospective, single-blind, placebo-controlled trial.
Interdisciplinary Smell and Taste Clinic, TU Dresden (tertiary referral centre).
Forty-nine adult participants with post-infectious olfactory impairment (M : F = 11 : 38, mean age 58.71 ± 11.03 years).
Olfactory function (odour threshold and identification) before and after treatment as determined using "Sniffin' Sticks". Patients were treated monorhinally with 1 mL sodium citrate solution. The contralateral nasal cavity was treated with 1 mL physiological sodium chloride solution, which acted as internal control. Clinical improvement was assumed where threshold or identification score increased by ≥2.5 or 3 points, respectively, or ≥5.5 points together.
We demonstrated a statistically significant improvement in composite threshold + identification scores following treatment with sodium citrate, compared with placebo. This was true for all patients (mean improvement 0.87 ± 2.68 points, P = 0.04), and on subgroup analysis in those with hyposmia (mean improvement 1.15 ± 2.37 points, P = 0.02). However, the effect size did not reach clinical significance.
Further basic and clinical work is required to fully delineate the effect of intranasal sodium citrate in the treatment of post-infectious olfactory loss.
游离钙在周围嗅觉处理过程中,包括反馈抑制,发挥着不可或缺的作用。因此,有人提出用柠檬酸钠等缓冲溶液降低鼻内游离钙含量,可能会改善嗅觉受损患者的嗅觉功能。此前的多项研究支持了这一假设,尤其在感染后嗅觉丧失方面。因此,我们旨在确定鼻内使用柠檬酸钠治疗是否能改善感染后嗅觉受损患者的嗅觉功能。
前瞻性、单盲、安慰剂对照试验。
德累斯顿工业大学跨学科嗅觉和味觉诊所(三级转诊中心)。
49名感染后嗅觉受损的成年参与者(男∶女 = 11∶38,平均年龄58.71±11.03岁)。
使用“嗅棒”测定治疗前后的嗅觉功能(气味阈值和识别能力)。患者单鼻腔接受1 mL柠檬酸钠溶液治疗。对侧鼻腔用1 mL生理氯化钠溶液治疗,作为内部对照。当阈值或识别分数分别提高≥2.5或3分,或两者合计提高≥5.5分时,认为临床有改善。
与安慰剂相比,我们发现用柠檬酸钠治疗后,综合阈值 + 识别分数有统计学意义的改善。所有患者均如此(平均改善0.87±2.68分,P = 0.04),在嗅觉减退亚组分析中也是如此(平均改善1.15±2.37分,P = 0.02)。然而,效应大小未达到临床意义。
需要进一步开展基础和临床研究,以全面阐明鼻内柠檬酸钠在治疗感染后嗅觉丧失中的作用。